David Williamson Articles

•   RSS Feed
• View Profile

Last 50 articles...

• FDA Green Light = Surprise Share Surge
• Everyone Wins From This Acquisition
• Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
• The Implications of Monsanto's Supreme Court Win
• Cloning: A Stem Cell Revolution?
• Cancer Drug Drama Rocks 2 Biotech Stocks
• Presentation Pandemonium = 30% Pop
• Why Bristol-Myers Is Soaring
• FDA Prioritizes New Hepatitis C Drug
• The Danger of Chasing This IPO's Profits
• Do Micro-Cracks Equal Major Problems?
• Curing Back Pain and Preventing Diabetes
• The Real Impact of Irrational Hospital Pricing
• How the Patent Cliff Is Shrinking U.S. Spending
• No Relief in Sight for Pain Therapeutics Investors
• 1 Biotech's Surprise Dilution Decoded
• Dendreon: Picking Through the Carnage
• Deal Discussions Distract From Disappointing Obesity Drug Sales
• Are Insurers Exaggerating Medicare Advantage Cuts?
• A "Me Too" FDA Breakthrough
• The Potential Death Knell of a Multibillion-Dollar Industry
• Does Ariad's Leukemia Drug Have Hidden Potential?
• Picking Up the Pieces of Another Alzheimer's Failure
• What Gov. Christie's Secret Weight-Loss Surgery Means for Investors
• This Health-Care Revolution Is Only Just Beginning
• This Week's Must-Watch Stock: Dendreon
• Gilead's Game-Changer Delivers the Goods
• Are Obesity Drugs a Lost Cause in Europe?
• Why Investors Shouldn't Worry About Sanofi's Poor Quarter
• An FDA Advisory Committee Kill Shot
• The FDA Firing Squad Takes Aim
• The Great Acquirer Strikes Again
• Aetna Succeeding As Obamacare Looms
• Why Pfizer's Bad Outlook Doesn't Matter
• Europe Hands Down 2 Critical Drug Decisions
• Is Peregrine Preparing to Soar Again?
• The FDA Issues a Stunning Rejection
• Does This Common Vegetable Hold the Migraine Cure?
• Breaking Down AbbVie's Big Upgrade
• Tough Day for This Hepatitis C Underdog
• How This Big Pharma Is Staging a Big Comeback
• A New Cure for Painkiller Constipation
• Big Pharma Frantically Plays Catch-Up
• Early Lessons From Earnings Season
• Obama's Budget Bludgeons Big Pharma
• The Other Landmark Supreme Court Case
• Obamacare and Sequestration Crush UnitedHealth
• Is This Stock the Next Big Biotech?
• Not Exactly What Investors Were Looking For
• Marking the Way for Alzheimer's Drugs